ORIGINAL RESEARCH article

Front. Chem., 16 May 2019

Sec. Organic Chemistry

Volume 7 - 2019 | https://doi.org/10.3389/fchem.2019.00345

Three-Component Reaction of 3-Arylidene-3H-Indolium Salts, Isocyanides, and Alcohols

  • 1. Department of Organic Chemistry, Faculty of Science, Peoples' Friendship University of Russia (RUDN University), Moscow, Russia

  • 2. Laboratory for Organic & Microwave-Assisted Chemistry (LOMAC), Department of Chemistry, University of Leuven (KU Leuven), Leuven, Belgium

Abstract

A novel isocyanide-based multicomponent synthesis of alkyl aryl(indol-3-yl)acetimidates has been established. Starting from aryl(indol-3-yl)methylium tetrafluoroborates, aromatic isocyanides and alcohols, the imidates were obtained in moderate to very good yields. Consecutive four-component synthesis of the above mentioned imidates from N-alkylindoles, aromatic aldehydes, aromatic isocyanides and alcohols was also proposed. In addition, it was shown that in the presence of water, aryl(indol-3-yl)methylium tetrafluoroborates reacted with isocyanides to furnish aryl(indol-3-yl)acetamides.

Introduction

Multicomponent reactions (MCRs) serve as a powerful and widely used instrument in organic synthesis (Shiri, 2012; Müller, 2014; Zarganes-Tzitzikas et al., 2015; Zhu et al., 2015; Levi and Müller, 2016). A special place among them is occupied by transformations with the participation of isocyanides, unique reagents where nucleophiles and electrophiles attack the same atom (for a book on isocyanides, see Nenajdenko, 2012; for selected reviews on isocyanide-based MCR, see Dömling and Ugi, 2000; Dömling, 2006; Sadjadi et al., 2016). Common reaction partners in MCR with isocyanides are iminium salts, carbonyl compounds (or oxocarbenium ions), and electron-deficient alkynes (Ugi, 1962; Banfi and Riva, 2005; De Moliner et al., 2011). Several examples of interaction between isocyanides and activated alkenes were reported (Saegusa et al., 1972; Person et al., 1980; Shaabani et al., 2002; Maltsev et al., 2006; Mironov et al., 2006; Jing et al., 2010; Soleimani and Zainali, 2011; Soleimani et al., 2011, 2013). Reactions of isocyanides with α,β-unsaturated imines or the corresponding iminium salts with the possibility of 1,4-addition are still rare (Marchand et al., 1999; Fontaine et al., 2009; Shimizu et al., 2009). Particularly, such imine and iminium salts were used in a formal [4+1] cycloaddition reaction with the formation of a pyrrole ring (Marchand et al., 1999; Fontaine et al., 2009; Kaur et al., 2016). In our opinion, the interaction of isocyanides with α,β-unsaturated imines could well-evolve into a novel multicomponent reaction.

Considering that the indole scaffold is privileged from medicinal chemistry point of view (Barreiro, 2016), we decided to use 3-arylidene-3H-indolium salts as simple vinylogues of iminium ions. Alkylideneindoleninium (3-alkylidene-3H-indolium) ions (I) can be formed as intermediates by cleaving the leaving group from the α-position (“benzylic”) of the substituent at the indole 3-position (Figure 1A) (For reviews, concerning generation and reactivity of alkylideneindolenine intermediates, see Enders et al., 2008; Shaikh et al., 2008; Palmieri et al., 2010; Wang et al., 2014; Zhuo et al., 2014; Jin et al., 2015; Palmieri and Petrini, 2016; Deb et al., 2017; Mei and Shi, 2017). Such intermediates are usually unstable and can react in situ with nucleophiles. This approach has been widely used in the syntheses of various indole derivatives (Enders et al., 2008; Shaikh et al., 2008; Palmieri et al., 2010; Wang et al., 2014; Zhuo et al., 2014; Jin et al., 2015; Palmieri and Petrini, 2016; Deb et al., 2017; Mei and Shi, 2017).

Figure 1

Moreover, relatively stable 3-arylidene-3H-indolium (aryl(indol-3-yl)methylium) ions II were obtained by acid-catalyzed coupling of indoles and aryl aldehydes, and were isolated and characterized as o-benzenedisulfonimide salts (Figure 1B) (Barbero et al., 2012). The corresponding diarylmethanes were obtained by reduction of these salts (Barbero et al., 2012), and an organocatalytic addition of aliphatic aldehydes to such compounds was developed (Armenise et al., 2015). Recently, an efficient synthesis for a bench-stable aryl(indol-3-yl)methyl tetrafluoroborate has been proposed (Figure 1B) (Barbero et al., 2015; Follet et al., 2015). Lewis acidity of such obtained aryl(indol-3-yl)methylium ions and kinetics of their interaction with different nucleophiles, including allylsilanes, enol silyl ethers, triarylphosphines, pyridines, secondary amines, have been studied (Follet et al., 2015, 2016). It should also be mentioned that the vinylogous iminium character of salts II was confirmed by single-crystal X-ray diffraction analysis (Barbero et al., 2015; Follet et al., 2015).

To the best of our knowledge, reactions of alkylideneindolenines or the corresponding salts with isocyanides have not been published yet. Herein, we report the three-component reaction of 3-arylidenindolium salts with isocyanides and alcohols to form alkyl aryl(indol-3-yl)acetimidates.

Results and Discussion

Starting salts 1a-f were obtained by alkylation of the corresponding indoles followed by reaction of N-benzylindoles 2a-c with aromatic aldehydes 3a-c under conditions similar to a previously published procedure (Figure 2) (Follet et al., 2015). Tetrafluoroborates 1a-f containing a benzyl group in the indole 1-position remained unchanged after being stored at room temperature for several weeks and turned out to be more stable than their methyl analogs, whose lability was observed previously (Follet et al., 2015). In solution salts 1a-f exist as a mixture of E- and Z-isomers (for copies of NMR spectra of obtained compounds, see Supplementary Material), what was also noted for 2-unsubstituted derivatives earlier (Follet et al., 2015).

Figure 2

Next, the interaction of salt 1a with p-methoxyphenyl isocyanide (4a) in methanol (5a) was performed at room temperature. After treating the reaction mixture with sodium bicarbonate solution, the imidate 6a was isolated in moderate yield as a result of the expected three component interaction (Figure 3; Table 1, entry 1). This was stable upon chromatography on silica gel and further storage for several weeks. Unfortunately, our attempt to facilitate the reaction by heating was unsuccessful, due to significant tar formation (Table 1, entry 2). The addition of potassium carbonate as a base increased the yield (Table 1, entries 4, 7, 8), but led to the formation of ether 7, resulting from the two-component reaction with methanol. Sodium or cesium carbonate had nearly the same effect, while Et3N was less effective (Table 1, entries 3, 5, 6).

Figure 3

Table 1

EntryMeOH (equiv.)SolventBase (equiv.)Temperature (°C)Time (h)Yield (%)d
1a80MeOH-2024 h30
2a80MeOH-653 h25
3a80MeOHNa2CO3 (1.0)2012 h45 (traces)
4a80MeOHK2CO3 (1.0)2012 h47 (traces)
5a80MeOHCs2CO3 (1.0)2012 h43 (traces)
6a80MeOHEt3N (1.0)2012 h36 (18)
7a80MeOHK2CO3 (1.5)2012 h51 (12)
8a80MeOHK2CO3 (2.0)2012 h48 (15)
9b80MeOHK2CO3 (1.5)2012 h28
10a4MeCNK2CO3 (1.5)2012 h48
11a40MeCN – MeOH (1:1)K2CO3 (1.5)206 h63
12a40MeCN – MeOH (1:1)K2CO3(1.5)2012 h65
13c80MeOHK2CO3 (1.5)2012 h(91)
14c80MeOH-2024 h(traces)

Reaction optimisation for imidate 6a synthesis.

a

1.3 equiv. 4a.

b

2.0 equiv. 4a.

c

0 equiv. 4a.

d

the yield of 7 is indicated in parentheses.

The formation of methoxy derivative 7 was not observed when the reaction was carried out in acetonitrile with 4 equiv of methanol and 1.5 equiv. of K2CO3, (Table 1, entry 10). However, the highest yield of the target product 6a was achieved by using a mixture of equal amounts of methanol and acetonitrile as solvent (Table 1, entry 12).

In these optimized conditions, the reaction was showing significant progress by TLC during the first 3 h. After 6 h, the yield did not change substantially (Table 1, entries 11 and 12). It is worth noting that increasing the amount of isocyanide resulted in a drop of the yield (Table 1, entry 9 vs. 7), whereas, performing the reaction without the addition of isocyanide in the presence of a base led to the formation of two-component reaction product 7. Without the addition of base, this product was only formed in trace amounts (Table 1, entries 13, 14).

With the optimized conditions in hand, the interaction of salts 1a-f with isocyanides 4a-d and methanol was investigated (Figure 4; Table 2). Moreover, salts 1g-j containing a methyl group at the indole nitrogen atom, which were obtained by a previously described procedure (Follet et al., 2015), were also involved. Reactions of aromatic isocyanides 4a-c led to the corresponding imidates 6 in moderate to good yields. The best results were observed for salts derived from anisaldehyde (Table 2, entries 2, 5). Such results can be explained by stabilization of the 3-arylidene-3H-indolium salts 1b,h with the donor substituent (MeO) and, consequently, by reducing the rate of the starting compound degradation under the reaction conditions, in comparison with more electrophilic salts 1a,c,g,i. At the same time, the stronger electron-donating dimethylamino group notably reduced the electrophilicity of the substrate, which led to lowering the yield of the reaction product with isonitrile 4a (Table 2, entry 7) (for electrophilicity parameters of salts 1j-g, see Follet et al., 2015). Similarly, the presence of an electron-donating methoxy group at the indole 5-position slightly increased the yield of the corresponding imidate 6j (Table 2, entry 1 vs. entry 10). The presence of a bromine atom in the same position decreased the yield (Table 2, entry 8, 9).

Figure 4

Table 2

EntrySaltRR1R2IsocyanideR3AlcoholR4ProductYield, %
11aBnHMe4a4-MeOC6H45aMe6a65
21bBnHMeO4a4-MeOC6H45aMe6b84
31cBnHH4a4-MeOC6H45aMe6c56
41gMeHMe4a4-MeOC6H45aMe6d51
51hMeHMeO4a4-MeOC6H45aMe6e87
61iMeHH4a4-MeOC6H45aMe6f78
71jMeHMe2N4a4-MeOC6H45aMe6g51
81dBnBrMe4a4-MeOC6H45aMe6h47
91eBnBrMeO4a4-MeOC6H45aMe6i52
101fBnMeOMe4a4-MeOC6H45aMe6j71
111aBnHMe4a4-MeOC6H45bEt6k53
121bBnHMeO4a4-MeOC6H45bEt6l47
131bBnHMeO4a4-MeOC6H45ci-Pr6m56
141aBnHMe4bPh5aMe6n51
151bBnHMeO4bPh5aMe6o63
161gMeHMe4bPh5aMe6p54
171bBnHMeO4c4-ClC6H45aMe6q43
181fBnMeOMe4c4-ClC6H45aMe6r37
191aBnHMe4dBn5aMe6s0a

Synthesis of imidates 6.

a

The corresponding amide 8a (see Table 4) was isolated in 17 % yield along with compound 7 in 25 % yield.

Among aromatic isocyanides, the best results were also achieved for isocyanide 4a containing an electron-donating methoxy group. Furthermore, the alcohol component of this MCR could be varied and the reaction was carried out in a mixture of acetonitrile with alcohols 5b,c (Table 2, entries 11-13).

It should be mentioned that, in case of the non-conjugated benzyl isocyanide 4d, it was not possible to isolate the corresponding imidate 6s. Within 12 h, the reaction did not show significant progress according to TLC. After work-up and purification by chromatography on silica gel, amide 8a was isolated in a low yield along with compound 7 (Table 2, entry 19). Apparently, the amide 8a was formed by hydrolysis of the corresponding imidate 6s.

Next, the possibility of imidate synthesis from the indole and the aldehyde by a sequential one-pot four-component process, without isolation of the corresponding 3-arylidene-3H-indolium salt, was investigated (Figure 5; Table 3). After acid-catalyzed condensation of the aldehyde with 1-alkylindole, an excess of K2CO3 and a solution of isocyanide in the appropriate alcohol were added to the reaction mixture. To our great satisfaction, target imidate 6 was obtained in moderate to good yields.

Figure 5

Table 3

EntryProductRR1R2R3R4Yield, %
16bBnHMeO4-MeOC6H4Me74
26eMeHMeO4-MeOC6H4Me77
36fMeHH4-MeOC6H4Me68
46gMeHMe2N4-MeOC6H4Me24
56iBnBrMeO4-MeOC6H4Me40
66jBnMeOMe4-MeOC6H4Me56
76lBnHMeO4-MeOC6H4Et37
86mBnHMeO4-MeOC6H4i-Pr46
96nBnHMePhMe41
106qBnHMeO4-ClC6H4Me36

Consecutive four-component synthesis of imidates 6a.

a

Reaction conditions: 1.0 equiv. of aldehyde, 1.5 equiv. HBF4OEt2, CH2Cl2, 0 – 20°C then, 1.3 equiv. 4, 2.0 equiv. K2CO3, R4OH (1:1 to CH2Cl2), rt, 12 h.

Then we decided to extend our three-component imidate synthesis with the aim to obtain amides 8 (Figure 6; Table 4). As it turned out, addition of 10 volume % of water to the reaction mixture delivered the desired amides. Moreover, under these conditions, the reaction with benzyl isocyanide 4d also proceeded very quickly. A white precipitate of the corresponding amide 8a appeared almost immediately after isocyanide 4d addition. The interaction with aromatic isocyanides 4a,c was slightly slower but also efficient (Table 4, entries 7 and 8). Thus, 8 examples of amides 8 were obtained in a moderate to good yields employing this procedure (Table 4).

Figure 6

Table 4

EntryProductRR1R2R3Yield (%)
18aBnHMeBn59
28bBnHMeOBn63
38cMeHMeOBn53
48dMeHHBn50
58eBnBrMeBn51
68fBnMeOMeBn57
78gBnHMeO4-MeOC6H444
88hBnHMeO4-ClC6H454

Synthesis of amides 8a.

a

Reaction conditions: 1.3 equiv. 4, 1.5 equiv. K2CO3, MeOH – MeCN – H2O (1:1:0.2), r.t., 12 h.

Previously, low yields were observed in formation of imidates with the conjugate addition of alkyl isocyanides to methyl acrylate and acrylonitrile in methanol (Saegusa et al., 1971). Amides were reported to be formed in reaction of dicyanoethylenes with isocyanides (Soleimani et al., 2011). Based on these facts and on the reported reactivity of 3-arylidene-3H-indolium salts (Follet et al., 2015, 2016), as well as on our own experiments, we suggest the following pathway for the multicomponent transformation of 3-arylidene-3H-indolium salts (Figure 7). The conjugate nucleophilic addition of isocyanide to the vinylogous iminium ion 1 leads to nitrilium salt A, which is further attacked by the nucleophile. This could be an alcoholate ion (or the corresponding alcohol). As a result, the imidate 4 is formed. Therefore, the role of the base in this process is to generate a small concentration of alcoholate ion as a strong nucleophile and to bind the released HBF4.

Figure 7

The unsuccessful attempt of the three-component reaction with non-conjugated isocyanide 4d can be explained by the reversibility of the process and the lower stability of the corresponding imidate. In the case that water is present, the hydroxide ion acts as nucleophile leading to the imidic acid B, which is in equilibrium with the corresponding amide 8. This last step makes the entire sequence of reactions almost irreversible.

Conclusions

We have elaborated a three-component reaction of a 3-arylidene-3H-indolium salt, an aromatic isocyanide and an alcohol, leading to a series of alkyl aryl(indol-3-yl)acetimidates with yields up to 87%. We have also established a consecutive four-component synthesis of the above mentioned imidates from a N-alkylindole, an aromatic aldehyde, an aromatic isocyanide and an alcohol. By using aqueous acetonitrile-methanol media we have expanded our method for the synthesis of aryl(indol-3-yl)acetamides. These reactions present a new practical synthetic approach to a series of compounds possessing a privileged indole scaffold and then also extend isocyanide-based MCRs by using vinylogous iminium ions.

Materials and Methods

General

Starting reagents were purchased from commercial sources and were used without any additional purification or were prepared according to literature procedures. 1H and 13C NMR spectra were acquired on a Jeol JNM-ECA 600 spectrometer (with operating frequencies of 600 and 150 MHz, respectively) at room temperature and referenced to the residual signals of the solvent. The solvents used for NMR were DMSO-d6 and CDCl3. Chemical shifts are reported in parts per million (δ/ppm). Coupling constants are reported in Hertz (J/Hz). The peak patterns are indicated as follows: s, singlet; d, doublet; t, triplet; q, quadruplet; m, multiplet; dd, doublet of doublets and br s, broad singlet. Infrared spectra were measured on an Infralum FT-801 FT/IR instrument. The wavelengths are reported in reciprocal centimeters (νmax /cm−1). Mass spectra were recorded with LCMS-8040 Triple quadrupole liquid chromatograph mass-spectrometer from Shimadzu (ESI) and Kratos MS-30 mass-spectrometer (EI, 70 eV). HRMS spectra were recorded on a Bruker MicrOTOF-Q II. Elemental analysis was performed on an Euro Vector EA-3000 elemental analyzer. The reaction progress was monitored by TLC and the spots were visualized under UV light (254 or 365 nm). Column chromatography was performed using silica gel (230–400 mesh). Melting points were determined on a SMP-10 apparatus and were uncorrected. Solvents were distilled and dried according to standard procedures.

Synthesis of Tetrafluoroborates 1a-f

1-Benzyl-3-(4-Methylbenzylidene)-3H-Indolium Tetrafluoroborate (1a); Typical Procedure

1H-Indole (5.00 g, 42.7 mmol) and benzyl chloride (7.30 ml, 63.4 mmol) were dissolved in 10 ml of dry DMSO and finely ground KOH (3.5 g, 62.5 mmol) was added at 0–5°C in one portion. The reaction mixture was stirred at r.t. for 3 h and then poured into 100 mL of cold water. The product was extracted with ether (2 × 50 mL). The combined organic layers were washed with water (50 mL), brine (30 mL) and dried over anhydrous Na2SO4, after which the solvent was removed in vacuo. The residue was purified by flash chromatography on short column of silica gel (EtOAc – hexane, 20:1) to afford 1-benzyl-3H-indole (2a) (8.6 g, 97%) as white crystals.

1-Benzyl-1H-indole (2a) (1.00 g, 4.82 mmol) and p-tolualdehyde (3a) (4.82 mmol) were dissolved in a mixture of dry CH2Cl2 (5 mL) and Et2O (5 mL). Then HBF4·OEt2 (1.00 ml, 7.35 mmol) was added dropwise at 0–5°C over a period of 2 min. The reaction mixture was allowed to warm to r.t. and stirred for 20 min. The resulting precipitate was filtered, washed thoroughly with Et2O (5 × 20 mL) to give 1-benzyl-3-(4-methylbenzylidene)-3H-indolium tetrafluoroborate.

Yield: 1.78 g (93%); bright orange solid; mp 201–203°C (dec.).

IR (film): 3438, 3127, 1736, 1621, 1587, 1527, 1447, 1369, 1299, 1257, 1186, 1100, 1073, 1048, 813, 761, 711 cm−1.

1H NMR (600 MHz, CDCl3+TFA; ~ 3:1 Z/E diastereomeric mixture): δ = 9.17 (s, 0.67 H), 8.91 (s, 0.33 H), 8.82 (s, 0.67 H), 8.71 (s, 0.33 H), 8.32 (d, J = 8.1 Hz, 0.33 H), 8.01 (d, J = 8.0 Hz, 0.67 H), 7.97 (d, J = 8.1 Hz, 0.67 H), 7.91–7.85 (m, 1.33 H), 7.65–7.52 (m, 3 H), 7.50–7.36 (m, 7 H), 5.70 (s, 1.33 H), 5.60 (s, 0.67 H), 2.54 (s, 1 H), 2.49 (s, 2 H).

13C NMR (150 MHz, CDCl3+TFA): δ = 165.3, 160.6, 159.7, 153.4, 150.6, 149.7, 141.6, 139.9, 134.8, 134.2, 131.7, 131.4, 131.0, 130.95, 130.90, 130.6, 130.1, 129.97, 129.94, 129.86, 129.7, 129.64, 129.60, 129.2, 128.5, 128.45, 128.3, 127.09, 127.07, 125.2, 124.1, 121.2, 115.1, 115, 54.7, 54.2, 22.5, 22.3.

HRMS (TOF ES+): m/z [M – ]+ calcd for C23H20N+: 310.1590; found: 310.1596.

1-Benzyl-3-(4-Methoxylbenzylidene)-3H-Indolium Tetrafluoroborate (1b)

Red solid; yield 1.97 g (99% from 1.00 g 1-benzyl-1H-indole (2a)); mp 214-216°C (dec.).

IR (film): 3130, 2956, 2917, 2847, 1736, 1581, 1556, 1520, 1441, 1370, 1281, 1262, 1173, 1098, 1062, 835, 760, 710, 587 cm−1.

1H NMR (600 MHz, CDCl3+TFA; ~ 2.3:1 Z/E diastereomeric mixture): δ = 9.06 (s, 0.7 H), 8.75 (s, 0.7 H), 8.72 (s, 0.3 H), 8.62 (s, 0.3 H), 8.37 – 8.32 (m, 0.3 H), 8.16 (d, J = 9.0 Hz, 0.6 H), 8.04 (d, J = 8.6 Hz, 1.4 H), 7.99 (d, J = 8.1 Hz, 0.7 H), 7.66 – 7.52 (m, 3 H), 7.48 – 7.34 (m, 5 H), 7.22 – 7.15 (m, 2 H), 5.68 (s, 1.4 H), 5.58 (s, 0.6 H), 4.04 (s, 0.9 H), 4.01 (s, 2.1 H).

13C NMR (150 MHz, CDCl3+TFA): δ = 169.2, 168.3, 164.5, 159.0, 158.6, 150.9, 142.4, 139.5, 138.7, 138.5, 131.9, 131.3, 130.1, 130.0, 129.97, 129.95, 129.90, 129.13, 129.10, 129.0, 128.9, 128.5, 128.1, 127.5, 127.0, 126.9, 125.3, 124.4, 123.7, 120.7, 117.2, 116.3, 114.8, 114.5, 56.6, 56.5, 54.4, 53.9.

HRMS (TOF ES+): m/z [M – ]+ calcd for C23H20NO+: 326.1539; found: 326.1550.

1-Benzyl-3-Benzylidene-3H-indolium Tetrafluoroborate (1c)

Bright orange solid; yield 1.64 g (89% from 1.00 g 1-benzyl-1H-indole (2a)); mp 163-165°C (dec.).

IR (film): 3416, 3115, 1619, 1605, 1587, 1568, 1531, 1447, 1370, 1296, 1253, 1192, 1099, 1050, 826, 759, 710, 678, 599, 570 cm−1.

1H NMR (600 MHz, CDCl3+TFA; ~ 1.7:1 Z/E diastereomeric mixture): δ = 9.15 (s, 0.63 H), 8.93 (s, 0.37 H), 8.90 (s, 0.63 H), 8.74 (s, 0.37 H), 8.29 (d, J = 7.7 Hz, 0.37 H), 8.04 (d, J = 7.7 Hz, 0.63 H), 8.02 (d, J = 8.0 Hz, 0.76 H), 7.92 (d, J = 7.7 Hz, 1.26 H), 7.80 – 7.72 (m, 1 H), 7.69 – 7.56 (m, 5 H), 7.48 – 7.36 (m, 5 H), 5.72 (s, 1.26 H), 5.62 (s, 0.76 H).

13C NMR (150 MHz, CDCl3+TFA): δ = 165.0, 161.4, 159.6, 154.5, 142.9, 140.4, 136.9, 136.4, 134.1, 133.72, 133.70, 133.4, 133.3, 131.03, 131.0, 130.7, 130.6, 130.5, 130.4, 130.3, 130.2, 130.1, 130.03, 130.0, 129.97, 128.7, 128.6, 125.4, 128.2, 125.1, 124.3, 121.6, 115.3, 115.2, 55.0, 54.5.

HRMS (TOF ES+): m/z [M – ]+ calcd for C22H18N+: 296.1434; found: 296.1441.

1-Benzyl-5-Bromo-3-(4-Methylbenzylidene)-3H-Indolium Tetrafluoroborate (1d)

Bright orange solid; yield 1.35 g (81% from 1.00 g 1-benzyl-5-bromo-1H-indole (2b)); mp 220-222°C (dec.).

IR (film): 3126, 1736, 1620, 1587, 1526, 1448, 1424, 1372, 1319, 1259, 1188, 1104, 1051, 802, 772, 743, 714, 653, 629 cm−1.

1H NMR (600 MHz, CDCl3+TFA; ~ 2.3:1 Z/E diastereomeric mixture): δ = 9.13 (s, 0.70 H), 8.85 (s, 0.70 H), 8.83 (s, 0.30 H), 8.76 (s, 0.30 H), 8.49 (d, J = 2.0 Hz, 0.30 H), 8.18 (d, J = 2.0 Hz, 0.70 H), 7.99 (d, J = 8.1 Hz, 0.60 H), 7.90 (d, J = 8.1 Hz, 1.40 H), 7.75 (dd, J = 8.7 Hz, 1.7 Hz, 0.30 H), 7.71 (dd, J = 8.7 Hz, 1.7 Hz, 0.70 H), 7.56 (d, J = 8.1 Hz, 0.60 H), 7.52 (d, J = 8.1 Hz, 1.70 H), 7.50 – 7.42 (m, 3.70 H), 7.42 – 7.36 (m, 2 H), 5.71 (s, 1.40 H), 5.62 (s, 0.60 H), 2.59 (s, 0.90 H), 2.54 (s, 2.10 H).

13C NMR (150 MHz, CDCl3+TFA): δ = 167.1, 161.3, 160.3, 153.2, 152.3, 151.4, 141.6, 138.9, 135.4, 134.8, 133.7, 133.0, 132.2, 131.7, 131.58, 131.57, 131.5, 131.1, 130.7, 130.5, 130.4, 130.24, 130.2, 128.7, 128.4, 128.2, 127.2, 126.1, 124.5, 124.4, 124.2, 117.5, 116.5, 116.4, 55.3, 54.7, 22.4, 22.2.

HRMS (TOF ES+): m/z [M – ]+ calcd for C23H19BrN+: 388.0695; found: 388.0701.

1-Benzyl-5-Bromo-3-(4-Methoxylbenzylidene)-3H-Indolium Tetrafluoroborate (1e)

Red orange solid; yield 1.46 g (85% from 1.00 g 1-benzyl-5-bromo-1H-indole (2b)); mp 226-228°C (dec.).

IR (film): 3464, 3129, 2841, 1582, 1554, 1520, 1447, 1429, 1375, 1319, 1281, 1178, 1103, 1051, 888, 835, 799, 773, 716, 629, 595, 556 cm−1.

1H NMR (600 MHz, CDCl3+TFA; ~ 3.3:1 Z/E diastereomeric mixture): δ = 9.07 (s, 0.77 H), 8.73 (s, 0.23 H), 8.72 (s, 0.77 H), 8.68 (s, 0.23 H), 8.45 (d, J = 1.5 Hz, 0.23 H), 8.16 (d, J = 9.1 Hz, 0.46 H), ), 8.13 (d, J = 1.5 Hz, 0.77 H), ), 8.08 (d, J = 9.1 Hz, 1.54 H), 7.71 (dd, J = 8.6 Hz, 1.5 Hz, 0.23 H), 7.64 (dd, J = 8.6 Hz, 1.5 Hz, 0.77 H), 7.48 (d, J = 8.6 Hz, 0.23 H), 7.46 – 7.39 (m, 3.77 H), 7.38 – 7.31 (m, 2 H), 7.24 (d, J = 8.9 Hz, 0.46 H), 7.21 (d, J = 8.9 Hz, 0.46 H), 5.67 (s, 1.54 H), 5.57 (s, 0.46 H), 4.07 (s, 0.69 H), 4.04 (s, 2.31 H).

13C NMR (150 MHz, CDCl3+TFA): δ = 170.3, 169.3, 165.8, 159.9, 158.3, 150.6, 141.0, 139.5, 139.1, 138.1, 132.8, 132.0, 131.7, 131.2, 130.7, 130.6, 130.3, 130.1, 130.0, 128.4, 128.2, 128.1, 127.5, 127.1, 127.0, 126.5, 125.5, 123.8, 123.2, 123.0, 117.6, 116.8, 116.0, 115.9, 56.8, 56.7, 54.7, 54.1.

HRMS (TOF ES+): m/z [M – ]+ calcd for C23H19BrNO+: 404.0645; found: 404.0651.

1-Benzyl-5-Methoxy-3-(4-Methylbenzylidene)-3H-Indolium Tetrafluoroborate (1f)

Dark violet solid; yield 1.50 g (83% from 1.00 g 1-benzyl-5-methoxy-1H-indole (2c)); mp 212-214°C (dec.).

IR (film): 3130, 2947, 1619, 1587, 1526, 1482, 1444, 1372, 1298, 1263, 1237, 1189, 1099, 1051, 916, 858, 808, 754, 705, 645 cm−1.

1H NMR (600 MHz, CDCl3+TFA; ~ 2.7:1 Z/E diastereomeric mixture): δ = 8.89 (s, 0.73 H), 8.78 (s, 0.73 H), 8.64 (s, 0.27 H), 8.59 (s, 0.27 H), 7.95 (d, J = 8.1 Hz, 0.54 H), 7.87 (d, J = 2.5 Hz, 0.27 H), ), 7.82 (d, J = 8.1 Hz, 1.46 H), ), 7.54 – 7.51 (m, 1 H), 7.50 – 7.41 (m, 5.73 H), 7.41 – 7.34 (m, 2 H), 7.14 (dd, J = 9.1 Hz, 2.5 Hz, 0.27 H), 7.10 (dd, J = 9.1 Hz, 2.5 Hz, 0.73 H), 5.63 (s, 1.46 H), 5.55 (s, 0.54 H), 3.96 (s, 2.19 H), 3.89 (s, 0.81 H), 2.54 (s, 0.81 H), 2.50 (s, 2.19 H).

13C NMR (150 MHz, CDCl3+TFA): δ = 164.3, 158.9, 158.7, 151.3, 150.4, 149.6, 136.8, 134.6, 134.1, 133.8, 131.8, 131.4, 131.2, 131.0, 130.9, 130.8, 130.7, 130.6, 130.3, 130.2, 130.1, 130.0, 129.3, 128.6, 128.3, 127.3, 127.2, 127.0, 116.8, 116.2, 116.13, 116.09, 110.0, 106.0, 56.44, 56.36, 55.0, 54.4, 22.4, 22.2.

HRMS (TOF ES+): m/z [M – ]+ calcd for C24H22NO+: 340.1696; found: 340.1701.

Synthesis of Imidates 6

Three-Component Synthesis of Imidates 6; General Procedure (GP1)

An isocyanide 4 (0.65 mmol) was dissolved in a mixture of abs. alcohol (1 mL) and MeCN (1 mL). A salt 1 (0.5 mmol) and K2CO3 (0.1 g, 0.75 mmol) were then added. The reaction mixture was stirred at r.t. for 12 h and concentrated in vacuo. The residue was dissolved in EtOAc (50 mL), washed with NaHCO3 (2 × 25 mL), brine (20 mL), and dried over anhydrous Na2SO4. The EtOAc was evaporated in vacuo. The residue was chromatographed on a column with silica gel with EtOAc–hexane.

Consecutive Four-Component Synthesis of Imidates 6; General Procedure (GP2)

N-Alkylindole (0.5 mmol) and aromatic aldehyde (0.5 mmol) were dissolved in dry CH2Cl2 (3 mL). HBF4·OEt2 (0.1 ml, 0.75 mmol) was then added dropwise at 0–5°C over a period of 2 min. The reaction mixture was allowed to warm to r.t. and stirred for additional 20 min. Then K2CO3 (0.14 g, 1.0 mmol), anhydrous alcohol (3 ml) and isocyanide 4 (0.65 mmol) were added. The reaction mixture was stirred at r.t. for 12 h and concentrated in vacuo. The residue was dissolved in EtOAc (50 mL), washed with NaHCO3 (2 × 25 mL), brine (20 mL) and dried over anhydrous Na2SO4. The EtOAc was evaporated in vacuo. The residue was chromatographed on a column with silica gel with EtOAc–hexane.

Methyl 2-(1-Benzyl-1H-Indol-3-yl)-N-(4-Methoxyphenyl)-2-(p-tolyl)acetimidate (6a)

Yield, obtained by following GP1: 154 mg (65%).

Yellowish oil; Rf = 0.47 (EtOAc–hexane, 1:6).

IR (film): 3028, 2925, 2834, 1733, 1661, 1609, 1583, 1506, 1465, 1354, 1303, 1238, 1178, 1032, 909, 831, 740, 696, 636 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.36 – 7.23 (m, 5H), 7.19 – 7.13 (m, 3H), 7.12 – 7.07 (m, 4H), 7.05 – 6.99 (m, 2H), 6.84 (d, J = 9.1 Hz, 2H), 6.74 (d, J = 9.1 Hz, 2H), 5.42 (s, 1H), 5.37 – 5.29 (m, 2H), 3.84 (s, 3H), 3.80 (s,3H), 2.33 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.6, 155.8, 141.8, 137.7, 137.1, 136.7, 136.4, 129.1 (2C), 128.8 (2C), 128.4 (2C), 128.0, 127.7, 127.4, 126.7 (2C), 122.4 (2C), 122.0, 119.7, 119.4, 114.4 (2C), 114.0, 109.9, 55.6, 53.7, 50.1, 42.7, 21.2.

MS (ESI): m/z = 475 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C32H31N2: 475.2380; found: 475.2375.

Methyl 2-(1-Benzyl-1H-indol-3-yl)-N,2-bis(4-methoxyphenyl)acetimidate (6b)

Yield, obtained by following GP1: 206 mg (84%).

Yield, obtained by following GP2: 181 mg (74%).

Yellowish oil; Rf = 0.33 (EtOAc–hexane, 1:5).

IR (film): 3029, 2997, 2939, 2834, 1734, 1656, 1609, 1583, 1508, 1465, 1301, 1238, 1177, 1104, 1034, 908, 834, 741, 696, 636 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.36 – 7.23 (m, 5H), 7.21 – 7.14 (m, 3H), 7.12 (d, J = 7.0 Hz, 2H), 7.07 – 7.00 (m, 2H), 6.88 – 6.82 (m, 4H), 6.79 – 6.74 (m, 2H), 5.41 (s, 1H), 5.37 – 5.28 (m, 2H), 3.86 (s, 3H), 3.81 (s, 3H), 3.80 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.7, 158.5, 155.8, 141.8, 137.7, 136.78, 132.2, 129.6 (2C), 128.9 (2C), 128.0, 127.7, 127.4, 126.7 (2C), 122.4 (2C), 122.0, 119.7, 119.4, 114.5(2C), 114.3, 113.8 (2C), 109.9, 55.6, 55.3, 53.67, 50.2, 42.4.

MS (ESI): m/z = 491 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C32H31N2: 491.2329; found: 491.2337.

Methyl 2-(1-Benzyl-1H-Indol-3-yl)-N-(4-Methoxyphenyl)-2-Phenylacetimidate (6c)

Yield, obtained by following GP1: yield 129 mg (56%).

Yellowish oil; Rf = 0.43 (EtOAc–hexane, 1:5).

IR (film): 3058, 3027, 2931, 2833, 2391, 1735, 1662, 1605, 1506, 1466, 1334, 1301, 1238, 1178, 1031, 908, 833, 738, 698, 627 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.32 – 7.29 (m, 2H), 7.28 – 7.25 (m, 5H), 7.24 – 7.22 (m, 3H), 7.15 (dd, J = 8.0, 7.2 Hz, 1H), 7.10 (d, J = 7.6 Hz, 2H), 7.03 – 6.99 (m, 2H), 6.82 (d, J = 8.6 Hz, 2H), 6.73 (d, J = 8.6 Hz, 2H), 5.44 (s, 1H), 5.35 – 5.27 (m, 2H), 3.83 (s, 3H), 3.79 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.4, 155.8, 141.8, 140.2, 137.7, 136.7, 128.9 (2C), 128.5 (2C), 128.4 (2C), 128.1, 127.7, 127.4, 126.8, 126.7 (2C), 122.4 (2C), 122.0, 119.7, 119.4, 114.5 (2C), 113.8, 109.9, 55.6, 53.7, 50.2, 43.1.

MS (ESI): m/z = 461 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C31H29N2: 461.2224; found: 461.2217.

Methyl N-(4-Methoxyphenyl)-2-(1-Methyl-1H-Indol-3-yl)-2-(p-tolyl)acetimidate (6d)

Yield, obtained by following GP1: yield 101 mg (51%)

Brownish oil; Rf = 0.50 (EtOAc–hexane, 1:5).

IR (film): 3048, 3000, 2941, 2833, 1663, 1505, 1465, 1372, 1237, 1179, 1031, 909, 833, 773, 740, 644 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.29 (d, J = 8.1 Hz, 1H), 7.24 (d, J = 8.1 Hz, 1H), 7.22 – 7.18 (m, 1H), 7.12 (d, J = 8.0 Hz, 2H), 7.08 (d, J = 8.0 Hz, 2H), 7.01 (m, 1H), 6.89 (s, 1H), 6.83 (d, J = 8.9 Hz, 2H), 6.73 (d, J = 8.9 Hz, 2H), 5.37 (s, 1H), 3.84 (s, 3H), 3.79 (s,3H), 3.76 (s, 3H), 2.32 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.6, 155.8, 141.8, 137.3, 137.0, 136.3, 129.1 (2C), 128.39, 128.37 (2C), 127.1, 122.4 (2C), 121.7, 119.4, 119.1, 114.4 (2C), 113.4, 109.3, 55.6, 53.7, 42.6, 32.9, 21.2.

MS (ESI): m/z = 399 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C26H27N2: 399.2067; found: 399.2035.

Methyl N,2-bis(4-Methoxyphenyl)-2-(1-Methyl-1H-Indol-3-yl)acetimidate (6e)

Yield, obtained by following GP1: 180 mg (87%).

Yield, obtained by following GP2: 160 mg (77%).

Brownish oil; Rf = 0.37 (EtOAc–hexane, 1:5).

IR (film): 3048, 2998, 2943, 2834, 2391, 1737, 1661, 1609, 1583, 1508, 1464, 1440, 1329, 1239, 1178, 1032, 908, 834, 740, 634 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.29 (d, J = 8.1 Hz, 1H), 7.23 (d, J = 8.1 Hz, 1H), 7.22 −7.19 (m, 1H), 7.14 (d, J = 9.1 Hz, 2H), 7.04 – 6.99 (m, 1H), 6.87 (s, 1H), 6.82 (d, J = 8.9 Hz, 2H), 6.80 (d, J = 8.9 Hz, 2H), 6.72 (d, J = 9.1 Hz, 2H), 5.34 (s, 1H), 3.84 (s, 3H), 3.79 (s, 3H), 3.78 (s, 3H), 3.76 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.7, 158.4, 155.7, 141.8, 137.1, 132.4, 129.5 (2C), 128.3, 127.1, 122.4 (2C), 121.7, 119.4, 119.1, 114.4 (2C), 113.7 (2C), 113.6, 109.3, 55.6, 55.3, 53.7, 42.3, 32.9.

MS (ESI): m/z = 415 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C26H27N2: 415.2016; found: 415.2025.

Methyl N-(4-Methoxyphenyl)-2-(1-Methyl-1H-Indol-3-yl)-2-Phenylacetimidate (6f)

Yield, obtained by following GP1: 150 mg (78%).

Yield, obtained by following GP2: 131 mg (68%).

Brownish oil; Rf = 0.50 (EtOAc–hexane, 1:3).

IR (film): 3108, 2996, 2938, 2901, 2834, 1738, 1664, 1604, 1547, 1503, 1439, 1372, 1304, 1239, 1180, 1155, 1105, 1032, 905, 845, 799, 743, 718, 650 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.30 (d, J = 8.2 Hz, 1H), 7.29 – 7.25 (m, 2H), 7.24 – 7.19 (m, 5H), 7.01 (m, 1H), 6.90 (s, 1H), 6.83 (d, J = 8.6 Hz, 2H), 6.73 (d, J = 8.6 Hz, 2H), 5.41 (s, 1H), 3.85 (s, 3H), 3.79 (s, 3H), 3.76 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.4, 155.8, 141.8, 140.3, 137.1, 128.49 (2C), 128.45, 128.4 (2C), 127.1, 126.8, 122.4 (2C), 121.8, 119.4, 119.1, 114.4 (2C), 113.2, 109.3, 55.6, 53.7, 43.0, 32.9.

MS (ESI): m/z = 385 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C25H25N2: 385.1911; found: 385.1911.

Methyl 2-(4-(Dimethylamino)phenyl)-N-(4-Methoxyphenyl) -2-(1-Methyl-1H-indol-3-yl) acetimidate (6g)

Yield, obtained by following GP1: 109 mg (51%).

Yield, obtained by following GP2: 51 mg (24%).

Brownish oil; Rf = 0.44 (EtOAc–hexane, 1:5).

IR (film): 3059, 2927, 2852, 1759, 1703, 1661, 1602, 1512, 1464, 1351, 1237, 1157, 1031, 945, 825, 740, 607 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.29 – 7.26 (m, 2H), 7.22 – 7.18 (m, 1H), 7.12 (d, J = 8.6 Hz, 2H), 6.99 – 7.04 (m, 1H), 6.88 (s, 1H), 6.83 (d, J = 8.6 Hz, 2H), 6.74 (d, J = 8.6 Hz, 2H), 6.73 – 6.66 (m, 2H), 5.31 (s, 1H), 3.83 (s, 3H), 3.79 (s, 3H), 3.75 (s, 3H), 2.93 (s, 6H).

13C NMR (150 MHz, CDCl3): δ = 164.0, 155.8, 141.9, 137.1, 129.5, 129.3, 128.4 (2C), 127.2, 122.5 (2C), 121.8, 121.7, 119.5, 119.0, 114.4 (2C), 114.0, 112.8 (2C), 109.3, 55.6, 53.7, 42.2, 41.0 (2C), 32.9.

MS (ESI): m/z = 428 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C27H30N3: 428.2333; found: 428.2208.

Methyl 2-(1-Benzyl-5-Bromo-1H-Indol -3-yl)-N-(4-Methoxyphenyl)-2-(p-tolyl)acetimidate (6h)

Yield, obtained by following GP1: 130 mg (47%)

Brown oil; Rf = 0.47 (EtOAc–hexane, 1:7).

IR (film): 3030, 2941, 2833, 1733, 1661, 1607, 1505, 1468, 1282, 1237, 1176, 1103, 1033, 909, 874, 828, 793, 765, 732, 697, 641 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.36 (d, J = 2.0 Hz, 1H), 7.34 – 7.27 (m, 3H), 7.21 (dd, J = 8.6, 2.0 Hz, 1H), 7.12 – 7.07 (m, 5H), 7.06 (d, J = 7.7 Hz, 2H), 7.02 (s, 1H), 6.85 (d, J = 9.1 Hz, 2H), 6.71 (d, J = 9.1 Hz, 2H), 5.33 (s, 1H), 5.32 – 5.24 (m, 2H), 3.83 (s, 3H), 3.81 (s, 3H), 2.33 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.3, 155.9, 141.6, 137.2, 136.7, 136.6, 135.3, 129.3 (2C), 129.2, 129.1, 128.9 (2C), 128.3 (2C), 127.9, 126.6 (2C), 124.9, 122.4 (2C), 122.3, 114.5 (2C), 113.6, 112.9, 111.5, 55.6, 53.8, 50.4, 42.5, 21.2.

MS (ESI): m/z = 553 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C32H30BrN2: 553.1485; found: 553.1505.

Methyl 2-(1-Benzyl-5-Bromo-1H -Indol-3-yl)-N,2-bis(4-Methoxyphenyl)acetimidate (6i)

Yield, obtained by following GP1: 148 mg (52%).

Yield, obtained by following GP2: 114 mg (40%).

Brownish oil; Rf = 0.60 (EtOAc–hexane, 1:5).

IR (film): 3030, 2996, 2943, 2834, 1734, 1662, 1608, 1508, 1467, 1354, 1238, 1176, 1104, 1033, 908, 832, 734, 697, 634 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.37 (d, J = 1.8 Hz, 1H), 7.33 – 7.25 (m, 3H), 7.20 (dd, J = 8.6, 1.8 Hz, 1H), 7.13 (d, J = 8.6 Hz, 2H), 7.08 (d, J = 8.6 Hz, 1H), 7.06 – 7.03 (m, 2H), 7.00 (s, 1H), 6.84 (d, J = 8.6 Hz, 2H), 6.82 (d, J = 9.1 Hz, 2H), 6.71 (d, J = 9.1 Hz, 2H), 5.31 (s, 1H), 5.31 – 5.23 (m, 2H), 3.82 (s, 3H), 3.80 (s, 3H), 3.78 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.3, 158.6, 155.9, 141.6, 137.2, 135.4, 131.7, 129.4 (2C), 129.1, 129.0, 128.9 (2C), 127.9, 126.6 (2C), 124.9, 122.3 (2C), 122.2, 114.5 (2C), 113.9 (2C), 113.8, 112.9, 111.4, 55.6, 55.3, 53.7, 50.4, 42.1.

MS (ESI): m/z = 569 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C32H30BrN2: 569.1434; found: 569.1412.

Methyl 2-(1-Benzyl-5-Methoxy-1H-Indol-3-yl)-N-(4-Methoxyphenyl)-2-(p-tolyl)acetimidate (6j)

Yield, obtained by following GP1: 179 mg (71%).

Yield, obtained by following GP2: 141 mg (56%).

Brown oil; yield; Rf = 0.56 (EtOAc–hexane, 1:5).

IR (film): 3030, 2994, 2939, 2833, 1734, 1661, 1621, 1578, 1506, 1487, 1452, 1288, 1238, 1176, 1103, 1030, 901, 830, 774, 704 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.31 – 7.25 (m, 3H), 7.15 (d, J = 8.1 Hz, 2H), 7.12 – 7.05 (m, 5H), 6.97 (s, 1H), 6.83 (d, J = 9.1 Hz, 2H), 6.79 (dd, J = 9.1, 2.5 Hz, 1H), 6.75 (d, J = 9.1 Hz, 2H), 6.70 (d, J = 2.5 Hz, 1H), 5.36 (s, 1H), 5.30 – 5.22 (m, 2H), 3.83 (s, 3H), 3.79 (s, 3H), 3.72 (s, 3H), 2.33 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.6, 155.8, 154.0, 141.9, 137.8, 137.80, 137.1, 136.4, 131.9, 129.1 (2C), 128.8 (2C), 128.6, 128.4 (2C), 127.8, 126.6 (2C), 122.5 (2C), 114.4 (2C), 113.5, 112.2, 110.7, 101.2, 55.8, 55.6, 53.7, 50.4, 42.6, 21.2.

MS (ESI): m/z = 505 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C33H33N2: 505.2486; found: 505.2461.

Ethyl 2-(1-Benzyl-1H-Indol-3-yl)-N-(4-Methoxyphenyl)-2-(p-tolyl)acetimidate (6k)

Yield, obtained by following GP1: 129 mg (53%)

Brownish oil; Rf = 0.71 (EtOAc–hexane, 1:5).

IR (film): 3030, 2976, 2946, 2901, 2833, 1732, 1656, 1610, 1505, 1466, 1357, 1334, 1306, 1236, 1178, 1103, 1036, 958, 834, 741, 696 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.34 – 7.23 (m, 5H), 7.17 – 7.13 (m, 3H), 7.11 (d, J = 8.1 Hz, 2H), 7.08 (d, J = 8.1 Hz, 2H), 7.05 (s, 1H), 6.99 – 7.00 (m, 1H), 6.83 (d, J = 9.1 Hz, 2H), 6.73 (d, J = 9.1 Hz, 2H), 5.40 (s, 1H), 5.31 (s, 2H), 4.34 – 4.27 (m, 2H), 3.80 (s, 3H), 2.33 (s, 3H), 1.26 (t, J = 7.1 Hz, 3H).

13C NMR (150 MHz, CDCl3): δ = 162.9, 155.7, 142.1, 137.7, 137.4, 136.7, 136.2, 129.0 (2C), 128.8 (2C), 128.4 (2C), 127.9, 127.7, 127.5, 126.8 (2C), 122.4 (2C), 121.9, 119.8, 119.2, 114.4 (2C), 114.2, 109.7, 61.8, 55.6, 50.1, 42.6, 21.1, 14.2.

MS (ESI): m/z = 489 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C33H33N2: 489.2537; found: 489.2553.

Ethyl 2-(1-Benzyl-1H-Indol-3-yl)-N,2-bis(4-Methoxyphenyl)acetimidate (6l)

Yield, obtained by following GP1: 118 mg (47%).

Yield, obtained by following GP2: 93 mg (37%).

Brownish oil; Rf = 0.71 (EtOAc–hexane, 1:3).

IR (film): 3031, 2930, 2834, 1727, 1658, 1609, 1508, 1465, 1301, 1238, 1177, 1104, 1036, 958, 834, 741, 696, 637 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.32 – 7.28 (m, 2H), 7.27 – 7.25 (m, 2H), 7.23 (d, J = 8.6 Hz, 1H), 7.16 (d, J = 8.4 Hz, 2H), 7.16 – 7.12 (m, 1H), 7.09 (d, J = 8.1 Hz, 2H), 7.02 (s, 1H), 7.02 – 6.98 (m, 1H), 6.81 (d, J = 8.6 Hz, 2H), 6.79 (d, J = 8.6 Hz, 2H), 6.71 (d, J = 8.6 Hz, 2H), 5.35 (s, 1H), 5.30 (s, 2H), 4.32 – 4.21 (m, 2H), 3.79 (s, 3H), 3.77 (s, 3H), 1.24 (t, J = 7.1 Hz, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.0, 158.4, 155.7, 142.0, 137.7, 136.7, 132.5, 129.5 (2C), 128.8 (2C), 127.8, 127.7, 127.4, 126.7 (2C), 122.4 (2C), 121.9, 119.8, 119.2, 114.4 (2C), 114.3, 113.7 (2C), 109.8, 61.8, 55.6, 55.3, 50.1, 42.3, 14.2.

MS (ESI): m/z = 505 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C33H33N2: 505.2486; found: 505.2506.

Isopropyl 2-(1-Benzyl-1H-Indol-3-yl)-N,2-bis(4-Methoxyphenyl)acetimidate (6m)

Yield, obtained by following GP1: 145 mg (56%).

Yield, obtained by following GP2: 119 mg (46%).

Brownish oil; yield; Rf = 0.43 (EtOAc–hexane, 1:8).

IR (film): 3056, 2933, 2837, 2736, 1683, 1654, 1600, 1577, 1509, 1465, 1302, 1250, 1160, 1178, 1108, 1030, 976, 834, 742, 698 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.35 – 7.29 (m, 2H), 7.28 – 7.25 (m, 2H), 7.23 (d, J = 8.2 Hz, 1H), 7.15 (d, J = 9.1 Hz, 2H), 7.13 – 7.08 (m, 3H), 7.03 (s, 1H), 7.02 – 6.98 (m, 1H), 6.81 (d, J = 8.6 Hz, 2H), 6.78 (d, J = 8.6 Hz, 2H), 6.70 (d, J = 9.1 Hz, 2H), 5.34 (s, 1H), 5.33 – 5.26 (m, 2H), 5.23 – 5.18 (m, 1H), 3.79 (s, 3H), 3.77 (s, 3H), 1.22 (d, J = 6.2 Hz, 3H), 1.17 (d, J = 6.2 Hz, 3H).

13C NMR (150 MHz, CDCl3): δ = 162.1, 158.3, 155.6, 142.2, 137.7, 136.6, 132.7, 129.5 (2C), 128.8 (2C), 127.8, 127.7, 127.5, 126.8 (2C), 126.5, 122.3 (2C), 121.8, 119.8, 119.1, 114.4 (2C), 113.6 (2C), 109.7, 68.0, 55.6, 55.3, 50.1, 42.2, 21.7, 21.6.

MS (ESI): m/z = 519 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C34H35N2: 519.2642; found: 519.2623.

Methyl 2-(1-Benzyl-1H-Indol-3-yl)-N-Phenyl-2-(p-tolyl)acetimidate (6n)

Yield, obtained by following GP1: 113 mg (51%).

Yield, obtained by following GP2: 91 mg (41%).

Orange oil; Rf = 0.41 (EtOAc–hexane, 1:10).

IR (film): 3055, 3028, 2941, 2861, 1665, 1595, 1546, 1511, 1466, 1334, 1249, 1178, 1072, 1017, 908, 834, 740, 695 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.34 – 7.29 (m, 2H), 7.28 – 7.25 (m, 3H), 7.25 – 7.22 (m, 2H), 7.15 – 7.11 (m, 3H), 7.10 – 7.03 (m, 5H), 7.02 – 6.98 (m, 2H), 6.79 (dd, J = 8.4, 1.1 Hz, 2H), 5.35 (s, 1H), 5.34 – 5.27 (m, 2H), 3.84 (s, 3H), 2.32 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.1, 148.6, 137.7, 137.0, 136.7, 136.40, 129.1 (2C), 129.1 (2C), 128.8 (2C), 128.4 (2C), 128.0, 127.6, 127.4, 126.7 (2C), 123.1, 121.9, 121.5 (2C), 119.7, 119.4, 113.9, 109.9, 53.7, 50.1, 42.9, 21.2.

MS (ESI): m/z = 445 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C31H29N2O+: 445.2274; found: 445.2250.

Methyl 2-(1-Benzyl-1H-Indol-3-yl)-2-(4-Methoxyphenyl)-N-Phenylacetimidate (6o)

Yield, obtained by following GP1: 145 mg (63%).

Orange oil; Rf = 0.66 (EtOAc–hexane, 1:5).

IR (film): 3030, 2928, 2837, 1738, 1664, 1594, 1510, 1465, 1303, 1247, 1175, 1031, 740 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.33 −7.29 (m, 2H), 7.28 – 7.21 (m, 5H), 7.16 – 7.12 (m, 3H), 7.10 – 7.07 (m, 2H), 7.07 – 7.03 (m, 1H), 7.00 (ddd, J = 8.1, 7.0, 1.0 Hz, 1H), 6.97 (s, 1H), 6.80 (d, J = 8.6 Hz, 2H), 6.79 (d, J = 8.6 Hz, 2H), 5.34 – 5.26 (m, 3H), 3.83 (s, 3H), 3.78 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.1, 158.5, 148.6, 137.7, 136.8, 132.1, 129.5 (2C), 129.1 (2C), 128.8 (2C), 127.9, 127.6, 127.3, 126.7 (2C), 123.1, 122.0, 121.5 (2C), 119.7, 119.4, 114.2, 113.8 (2C), 109.9, 55.3, 53.7, 50.1, 42.6.

MS (ESI): m/z = 461 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C31H29N2: 461.2224; found: 461.2239.

Methyl 2-(1-Methyl-1H-Indol-3-y l)-N-Phenyl-2-(p-tolyl)acetimidate (6p)

Yield, obtained by following GP1: 100 mg (54%)

Orange oil; Rf = 0.57 (EtOAc–hexane, 1:5).

IR (film): 3052, 3021, 2952, 2869, 2854, 1737, 1662, 1595, 1511, 1461, 1375, 1330, 1247, 1153, 1023, 900, 740, 698 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.30 – 7.26 (m, 3H), 7.23 – 7.17 (m, 2H), 7.12 (d, J = 8.1 Hz, 2H), 7.10 – 7.04 (m, 3H), 7.00 (ddd, J = 8.1, 7.0, 1.0 Hz, 1H), 6.88 (s, 1H), 6.79 (dd, J = 8.4, 1.2 Hz, 2H), 5.32 (s, 1H), 3.85 (s, 3H), 3.76 (s, 3H), 2.32 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.1, 148.6, 137.2, 137.0, 136.4, 129.1 (2C), 129.1 (2C), 128.4, 128.35 (2C), 127.1, 123.1, 121.7, 121.5 (2C), 119.4, 119.1, 113.3, 109.3, 53.8, 42.8, 32.9, 21.2.

MS (ESI): m/z = 369 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C25H25N2O+: 369.1961; found: 369.1961.

Methyl 2-(1-Benzyl-1H-Indol-3-yl)-N-(4-Chlorophenyl)-2-(4-Methoxyphenyl)acetimidate (6q)

Yield, obtained by following GP1: 106 mg (43%).

Yield, obtained by following GP2: 89 mg (36%).

Yellowish oil; yield; Rf = 0.53 (EtOAc–hexane, 1:5).

IR (film): 3028, 2948, 2836, 1736, 1666, 1610, 1510, 1466, 1302, 1242, 1176, 1092, 1031, 908, 835, 739 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.32 – 7.23 (m, 5H), 7.22 (d, J = 8.6 Hz, 2H), 7.19 – 7.12 (m, 3H), 7.08 (d, J = 7.2 Hz, 2H), 7.02 (ddd, J = 7.9, 7.0, 0.9 Hz, 1H), 6.95 (s, 1H), 6.81 (d, J = 9.1 Hz, 2H), 6.71 (d, J = 8.6 Hz, 2H), 5.34 – 5.22 (m, 3H), 3.83 (s, 3H), 3.78 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.1, 158.5, 147.2, 137.7, 136.8, 132.1, 129.5 (2C), 129.1 (2C), 128.8 (2C), 127.9, 127.6, 127.3, 126.7 (2C), 123.1, 121.95, 121.5 (2C), 119.7, 119.4, 114.2, 113.8 (2C), 109.9, 55.3, 53.7, 50.1, 42.6.

MS (ESI): m/z = 495 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C31H28ClN2: 495.1834; found: 495.1817.

Methyl 2-(1-Benzyl-5-Methoxy-1H-Indol-3-yl)-(4-Chlorophenyl)-2-(p-tolyl)acetimidate (6r)

Yield, obtained by following GP1: 94 mg (37%)

Brownish oil; Rf = 0.49 (EtOAc–hexane, 1:5).

IR (film): 3027, 2992, 2941, 2919, 2833, 1661, 1590, 1511, 1487, 1452, 1398, 1355, 1241, 1213, 1175, 1094, 1028, 903, 869, 829, 796, 732, 704, 643 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.31 – 7.28 (m, 2H), 7.28 – 7.25 (m, 1H), 7.23 (d, J = 8.6 Hz, 2H), 7.14 – 7.05 (m, 7H), 6.95 (s, 1H), 6.80 (dd, J = 8.6, 2.5 Hz, 1H), 6.73 (d, J = 8.6 Hz, 2H), 6.65 (d, J = 2.5 Hz, 1H), 5.29 – 5.22 (m, 3H), 3.83 (s, 3H), 3.72 (s, 3H), 2.32 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 163.7, 154.0, 147.3, 137.7, 136.7, 136.58, 131.9, 129.2 (2C), 129.1 (2C), 128.8 (2C), 128.6, 128.4, 128.3 (2C), 127.7, 127.7, 126.6 (2C), 122.9 (2C), 113.0, 112.3, 110.7, 101.0, 55.8, 53.9, 50.4, 42.9, 21.2.

MS (ESI): m/z = 509 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C32H30ClN2: 509.1990; found: 509.1962.

1-Benzyl-3-(Methoxy(p-tolyl)Methyl)-1H-Indole (7)

According to GP1 without an isocyanide addition compound 7 (155 mg, 91%) was obtained as an orange oil; Rf = 0.71 (EtOAc–hexane, 1:5).

IR (film): 3029, 2922, 2816, 1717, 1613, 1550, 1511, 1495, 1466, 1453, 1355, 1335, 1306, 1249, 1174, 1084, 1028, 956, 810, 777, 740, 695, 639, 573 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.63 (d, J = 8.1 Hz, 1H), 7.37 (d, J = 8.1 Hz, 2H), 7.29 – 7.23 (m, 3H), 7.22 (d, J = 8.1 Hz, 1H), 7.18 – 7.12 (m, 3H), 7.09 – 7.05 (m, 3H), 6.88 (s, 1H), 5.56 (s, 1H), 5.28 – 5.20 (m, 2H), 3.42 (s, 3H), 2.34 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 138.8, 137.6, 137.161, 129.1, 128.8, 127.6, 127.3, 127.2, 127.1, 126.7, 122.1, 120.2, 119.6, 117.2, 109.9, 79.6, 56.7, 50.1, 21.3.

MS (EI, 70 eV): m/z (%) = 341 (11) [M]+, 310 (63) [M – OCH3]+, 250 (7), 218 (6), 204 (6), 91 [C7H7]+ (100).

Synthesis of Amides 8

General Procedure

A salt 1 (0.5 mmol) and K2CO3 (100 mg, 0.75 mmol) were added to a solution of 0.65 mmol of isonitrile in a mixture of MeOH (1 mL), MeCN (1 mL) and H2O (0.2 mL). The reaction mixture was stirred at room temperature for 12 h. It was then diluted with 40 ml of EtOAc, washed with H2O (2 × 25 mL), brine (20 mL) and dried over anhydrous Na2SO4. The EtOAc was evaporated in vacuo. The residue was chromatographed on a column of silica gel with EtOAc–hexane.

N-Benzyl-2-(1-Benzyl-1H-Indol-3-yl)-2-(p-tolyl)acetamide (8a)

White solid; yield 132 mg (59%); mp 176–178°C; Rf = 0.42 (EtOAc–hexane, 1:3).

IR (film): 3299, 3087, 3029, 2949, 2920, 2874, 1645, 1612, 1532, 1496, 1433, 1356, 1334, 1222, 1030, 807, 768, 745, 696, 649 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.44 (d, J = 8.1 1H), 7.27 – 7.21 (m, 9H), 7.17 – 7.11 (m, 5H), 7.07 – 7.03 (m, 3H), 6.95 (d, J = 0.8 Hz, 1H), 6.12 (dd, J = 6.0, 5.7 Hz, 1H), 5.23 (s, 2H), 5.15 (s, 1H), 4.50 (dd, J = 15.1, 6.0 Hz, 1H), 4.41 (dd, J = 15.1, 5.7 Hz, 1H), 2.32 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 172.5, 138.4, 137.5, 137.0, 136.9, 136.5, 129.5 (2C), 128.8 (2C), 128.7 (2C), 128.5 (2C), 127.9, 127.7 (2C), 127.7, 127.5, 127.4, 126.7 (2C), 122.4, 119.8, 119.5, 114.0, 110.1, 50.9, 50.2, 43.8, 21.2.

MS (ESI): m/z = 445 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C31H29N2O+: 445.2274; found: 445.2301.

N-Benzyl-2-(1-Benzyl-1H-Indol-3-yl)-2-(4-Methoxyphenyl)acetamide (8b)

White solid; yield 144 mg (63%); mp 177–179°C; Rf = 0.41 (EtOAc–hexane, 1:3).

IR (film): 3328, 3062, 3028, 2930, 2837, 1735, 1642, 1610, 1510, 1466, 1354, 1303, 1243, 1179, 1029, 734, 698 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.42 (d, J = 8.1, 1H), 7.28 (d, J = 8.6 Hz, 2H), 7.26 – 7.21 (m, 7H), 7.19 – 7.13 (m, 3H), 7.07 – 7.02 (m, 3H), 6.95 (s, 1H), 6.85 (d, J = 8.6 Hz, 2H), 6.12 (dd, J = 6.1, 5.6 Hz, 1H), 5.24 (s, 2H), 5.13 (s, 1H), 4.50 (dd, J = 14.9, 6.1 Hz, 1H), 4.42 (dd, J = 14.9, 5.6 Hz, 1H), 3.78 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 172.6, 158.8, 138.4, 137.4, 137.0, 131.63, 129.7 (2C), 128.9 (2C), 128.7 (2C), 127.9, 127.7 (2C), 127.7, 127.4, 127.4, 126.7 (2C), 122.4, 119.8, 119.5, 114.2 (2C), 114.1, 110.1, 55.4, 50.5, 50.2, 43.8.

MS (ESI): m/z = 461 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C31H29N2: 461.2224; found: 461.2243.

N-Benzyl-2-(4-Methoxyphenyl)-2-(1-Methyl-1H-Indol-3-yl)acetamide (8c)

White solid; yield 101 mg (53%); mp 207–209°C; Rf = 0.26 (EtOAc–hexane, 1:3).

IR (film): 3280, 3088, 3006, 2920, 2835, 1647, 1607, 1557, 1507, 1473, 1419, 1342, 1248, 1223, 1174, 1031, 753 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.42 (d, J = 7.6, Hz, 1H), 7.30 – 7.20 (m, 7H), 7.18 −7.14 (m, 2H), 7.07 (ddd, J = 8.1, 7.0, 1.0 Hz, 1H), 6.86 (d, J = 9.1 Hz, 2H), 6.76 (s, 1H), 6.19 (dd, J = 6.1, 5.6 Hz, 1H), 5.12 (s, 1H), 4.51 (dd, J = 14.9, 6.1 Hz, 1H), 4.41 (dd, J = 14.9, 5.6 Hz, 1H), 3.79 (s, 3H), 3.70 (s, 3H)

13C NMR (150 MHz, CDCl3): δ = 173.0, 158.8, 138.3, 137.4, 131.6, 129.7 (2C), 128.7 (2C), 128.5, 127.8 (2C), 127.5, 127.1, 122.2, 119.5, 119.3, 114.2 (2C), 113.3, 109.5, 55.4, 50.3, 43.8, 32.9.

MS (ESI): m/z = 385 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C25H24N2: 385.1911; found: 385.1919.

N-Benzyl-2-(1-Methyl-1H-indol-3-yl)-2-Phenylacetamide (8d)

White solid; yield 88 mg (50%); mp 146–148°C; Rf = 0.29 (EtOAc–hexane, 1:3).

IR (film): 3256, 3050, 2940, 2098, 1736, 1634, 1542, 1475, 1451, 1372, 1335, 1216, 1152, 1111, 1029, 990, 745, 699, 584 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.44 (d, J = 8.1 Hz, 1H), 7.38 – 7.36 (m, 2H), 7.35 – 7.31 (m, 2H), 7.30 – 7.21 (m, 6H), 7.19 – 7.15 (m, 2H), 7.08 (ddd, J = 8.1, 7.0, 1.0 Hz, 1H), 6.77 (d, J = 1.0 Hz, 1H), 6.18 (dd, J = 6.1, 5.7 Hz, 1H), 5.16 (s, J = 6.8 Hz, 1H), 4.52 (dd, J = 15.5, 6.1 Hz, 1H), 4.42 (dd, J = 15.1, 5.7 Hz, 1H), 3.70 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 172.4, 139.7, 138.4, 137.3, 128.8 (2C), 128.7 (2C), 128.6 (2C), 128.6, 127.8 (2C), 127.5, 127.2, 127.1, 122.2, 119.6, 119.3, 113.1, 109.5, 51.2, 43.8, 32.9.

MS (ESI): m/z = 355 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C24H23N2O+: 355.1805; found: 355.1808.

N-Benzyl-2-(1-Benzyl-5-Bromo-1H-Indol-3-yl)-2-(p-tolyl)acetamide (8e)

White solid; yield 132 mg (51%); mp 184–186°C; Rf = 0.15 (EtOAc–hexane, 1:5).

IR (film): 3250, 3068, 3029, 2923, 1645, 1560, 1511, 1469, 1356, 1234, 1173, 1021, 869, 817, 802, 733, 697 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.55 (d, J = 2.0 Hz, 1H), 7.30 – 7.25 (m, 8H), 7.22 (dd, J = 8.6, 2.0 Hz, 1H) 7.17 (d, J = 7.1 Hz, 2H), 7.13 (d, J = 8.0 Hz, 2H), 7.06 (d, J = 8.6 Hz, 1H), 7.01 (dd, J = 7.6, 1.9 Hz, 2H), 7.00 (s, 1H), 6.07 – 6.02 (m, 1H), 5.21 (s, 2H), 5.05 (s, 1H), 4.52 – 4.43 (m, 2H), 2.32 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 172.1, 138.2, 137.2, 137.0, 136.0, 135.6, 129.7 (2C), 129.2, 129.1, 128.9 (2C), 128.8 (2C), 128.4 (2C), 127.9, 127.7 (2C), 127.5, 126.6 (2C), 125.2, 122.0, 113.5, 113.2, 111.6, 50.6, 50.5, 43.9, 21.2.

MS (ESI): m/z = 523 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C32H28BrN2O+: 523.1380; found: 523.1398.

N-Benzyl-2-(1-Benzyl-5-Methoxy-1H-Indol-3-yl)-2-(p-tolyl)acetamide (8f)

White solid; yield 135 mg (57%); mp 168–170°C; Rf = 0.13 (EtOAc–hexane, 1:5).

IR (film): 3283, 3031, 2923, 1649, 1622, 1489, 1453, 1352, 1228, 1171, 1032, 918, 822, 794, 742, 699 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.26 (d, J = 8.1 Hz, 2H), 7.25 – 7.21 (m, 6H), 7.16 (dd, J = 7.6, 2.0 Hz, 2H), 7.13 (d, J = 8.1 Hz, 2H), 7.09 (d, J = 8.6 Hz, 1H), 6.99 – 7.04 (m, 2H), 6.87 (s, 1H), 6.86 (d, J = 2.4 Hz, 1H), 6.80 (dd, J = 8.9, 2.4 Hz, 1H), 6.19 (dd, J = 6.1, 5.8 Hz, 1H), 5.19 (s, 2H), 5.11 (s, 1H), 4.51 (dd, J = 15.1, 6.1 Hz, 1H), 4.43 (dd, J = 15.1, 5.8 Hz, 1H), 3.72 (s, 3H), 2.33 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 172.5, 154.3, 138.4, 137.5, 136.9, 136.5, 132.2, 129.5 (2C), 128.8 (2C), 128.7 (2C), 128.6, 128.5 (2C), 127.8, 127.7 (2C), 127.7, 127.4, 126.6 (2C), 113.5, 112.7, 111.0, 101.0, 55.9, 50.9, 50.4, 43.8, 21.2.

MS (ESI): m/z = 475 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C32H31N2: 475.2380; found: 475.2399.

2-(1-Benzyl-1H-Indol-3-yl)-N,2-bis(4-Methoxyphenyl)acetamide (8g)

White solid; yield 105 mg (44%); mp 208–210°C; Rf = 0.57 (EtOAc–hexane, 1:3).

IR (film): 3287, 3255, 3196, 3134, 3058, 3024, 2962, 2835, 1655, 1606, 1546, 1509, 1469, 1410, 1346, 1303, 1251, 1171, 1031, 969, 833, 794, 746, 730, 700 cm−1.

1H NMR (600 MHz, DMSO-d6): δ = 10.20 (s, 1H), 7.53 (d, J = 9.1 Hz, 2H), 7.44 (s, 1H), 7.43 – 7.34 (m, 4H), 7.32 – 7.27 (m, 2H), 7.25 – 7.21 (m, 1H), 7.18 (d, J = 7.1 Hz, 2H), 7.09 – 7.04 (m, 1H), 6.99 – 6.95 (m, 1H), 6.90 – 6.84 (m, 4H), 5.41 (s, 2H), 5.26 (s, 1H), 3.71 (s, 3H) 3.70 (s, 3H).

13C NMR (150 MHz, DMSO-d6): δ = 170.2, 158.1, 155.2, 138.4, 136.1, 132.4, 132.3, 129.3 (2C), 128.5 (2C), 127.4, 127.3, 127.1, 127.0 (2C), 121.4, 120.7 (2C), 118.84, 118.82, 113.9 (2C), 113.7, 113.6 (2C), 110.2, 55.2, 55.0, 49.0, 48.6.

MS (ESI): m/z = 477 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C31H29N2: 477.2173; found: 477.2193.

2-(1-Benzyl-1H-Indol-3-yl)-N-(4-Chlorophenyl)-2-(4-Methoxyphenyl)acetamide (8h)

White solid; yield 132 mg (54%); mp 179–181°C; Rf = 0.30 (EtOAc–hexane, 1:4).

IR (film): 3282, 3061, 3030, 2928, 1658, 1593, 1510, 1493, 1467, 1397, 1299, 1248, 1173, 1093, 1030, 824, 786, 739, 697 cm−1.

1H NMR (600 MHz, CDCl3): δ = 7.65 (s, 1H), 7.44 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 9.0 Hz, 2H), 7.34 – 7.25 (m, 6H), 7.20 (d, J = 8.6 Hz, 2H), 7.19 – 7.16 (m, 1H), 7.10 – 7.06 (m, 3H), 7.01 (s, 1H), 6.87 (d, J = 8.6 Hz, 2H), 5.27 (s, 2H), 5.21 (s, 1H), 3.78 (s, 3H).

13C NMR (150 MHz, CDCl3): δ = 171.0, 159.0, 137.3, 137.1, 136.4, 131.1, 129.7 (2C), 129.4, 129.0 (2C), 128.9 (2C), 128.0, 127.8, 127.2, 126.8 (2C), 122.6, 121.2 (2C), 120.1, 119.3, 114.4 (2C), 113.6, 110.3, 55.4, 51.3, 50.3.

MS (ESI): m/z = 481 [M + H]+

HRMS (TOF ES+): m/z [M + H]+ calcd for C30H25ClN2: 481.1677; found: 481.1683.

Statements

Data availability statement

The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.

Author contributions

NG and HN were responsible for designing and performing the experiments. NG, HN, AG and AV discussed the evolution of the project and revised the manuscript together. LV and EV directed the project and wrote the publication.

Funding

We thank the Russian Science Foundation (grant 18-73-10099) for the financial support of this work.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fchem.2019.00345/full#supplementary-material

References

  • 1

    ArmeniseN.DugheraS.GualandiA.MengozziL.BarberoM.CozziP. G. (2015). Organocatalyzed asymmetric alkylation of stable aryl or heteroaryl(3-indolyl)methylium o-benzenedisulfonimides. Asian J. Org. Chem.4, 337345. 10.1002/ajoc.201402275

  • 2

    BanfiL.RivaR. (2005). “The passerini reaction,” in Organic Reactions, ed L. E. Overman (New York, NY: Wiley), 1140. 10.1002/0471264180.or065.01

  • 3

    BarberoM.BuscainoR.CadamuroS.DugheraS.GualandiA.MarabelloD.et al. (2015). Synthesis of bench-stable diarylmethylium tetrafluoroborates. J. Org. Chem.80, 47914796. 10.1021/acs.joc.5b00418

  • 4

    BarberoM.CadamuroS.CaudaF.DugheraS.GervasioG.VenturelloP. (2012). Preparation and characterization of aryl or heteroaryl(3-indolyl)methylium o-benzenedisulfonimides. J. Org. Chem.77, 42784287. 10.1021/jo300099y

  • 5

    BarreiroE. J. (2016). Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation.Cambridge: RSC Publishing.

  • 6

    De MolinerF. D.BanfiL.RivaR.BassoA. (2011). Beyond Ugi and Passerini reactions: multicomponent approaches based on isocyanides and alkynes as an efficient tool for diversity oriented synthesis. Comb. Chem. High Throughput Screen.14, 782810. 10.2174/138620711796957099

  • 7

    DebM. L.BorpatraP. J.SaikiaP. J.BaruahP. K. (2017). Base-promoted three-component one-pot approach to 3-(α,α-Diarylmethyl)indoles via arylation of 3-indolylalcohols. Synthesis49, 14011409. 10.1055/s-0036-15880098

  • 8

    DömlingA. (2006). Recent developments in isocyanide based multicomponent reactions in applied chemistry. Chem. Rev.106, 1789. 10.1021/cr0505728

  • 9

    DömlingA.UgiI. (2000). Multicomponent reactions with isocyanides. Angew. Chem. Int. Ed.39, 31693210. 10.1002/1521-773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U

  • 10

    EndersD.NarineA. A.ToulgoatF.BisschopsT. (2008). Asymmetric bronsted acid catalyzed isoindoline synthesis: enhancement of enantiomeric ratio by stereoablative kinetic resolution. Angew. Chem. Int. Ed.47, 56615665. 10.1002/anie.200801354

  • 11

    FolletE.BerionniG.MayerP.MayrH. (2015). Structure and reactivity of indolylmethylium ions: scope and limitations in synthetic applications. J. Org. Chem.80, 86438656. 10.1021/acs.joc.5b01298

  • 12

    FolletE.MayerP.MayrH. (2016). Lewis acidities of Indol-3-ylmethylium ions and intrinsic barriers of their reactions with phosphines and pyridines. Eur. J. Org. Chem.23, 40504058. 10.1002/ejoc.201600572

  • 13

    FontaineP.MassonG.ZhuJ. (2009). Synthesis of pyrroles by consecutive multicomponent reaction/[4 + 1] cycloaddition of α-iminonitriles with isocyanides. Org. Lett.11, 15551558. 10.1021/ol9001619

  • 14

    JinL.JingL.LuoG.WangR.YinM.WuC.et al. (2015). 3-(1-Arylsulfonylalkyl)-7-azaindoles as precursors of vinylogous imine intermediates for hetero-Michael addition reactions. Tetrahedron71, 40394046. 10.1016/j.tet.2015.04.062

  • 15

    JingL.WeiJ.ZhouL.HuangZ.LiZ.WuD.et al. (2010). Highly enantioselective michael addition of malononitrile to vinylogous imine intermediates generated in situ from arylsulfonyl indoles. Chem. Eur. J.16, 1095510958. 10.1002/chem.201001662

  • 16

    KaurT.WadhwaP.BagchiS.SharmaA. (2016). Isocyanide based [4+1] cycloaddition reactions: An indispensable tool in multi-component reactions (MCRs). Chem. Commun.52, 69586976. 10.1039/c6cc01562j

  • 17

    LeviL.MüllerT. J. (2016). Multicomponent syntheses of functional chromophores. Chem. Soc. Rev.45, 28252846. 10.1039/c5cs00805k

  • 18

    MaltsevS. S.MironovM. A.BakulevV. A. (2006). Synthesis of cyclopentene derivatives by the cyclooligomerization of isocyanides with substituted benzylidenemalononitriles. Mendeleev Commun.16, 201202. 10.1070/MC2006v016n04ABEH002354

  • 19

    MarchandE.MorelG.SinbandhitS. (1999). A new access to 2-(alkylamino)- and 2-(arylamino)pyrroles by addition of isocyanides to protonated 1-azabutadienes. Eur. J. Org. Chem.7, 17291738. 10.1002/(SICI)1099-0690(199907)1999:7<1729::AID-EJOC1729>3.0.CO;2-S

  • 20

    MeiG.J.ShiF. (2017). Indolylmethanols as Reactants in Catalytic Asymmetric Reactions. J. Org. Chem.82, 76957707. 10.1021/acs.joc.7b01458

  • 21

    MironovM. A.IvantsovaM. N.MokrushinV. S. (2006). A novel isocyanide-based multicomponent reaction: an easy access to substituted propionamides and succinimides. Synlett. 615617. 10.1055/s-2006-933104

  • 22

    MüllerT. J. J. (2014). Science of Synthesis: Multicomponent Reactions.Stuttgart: Thieme

  • 23

    NenajdenkoV. G. (2012). Isocyanide Chemistry: Applications in Synthesis and Material Science.Weinheim: Wiley-VCH.

  • 24

    PalmieriA.PetriniM. (2016). Sulfonyl azoles in the synthesis of 3-functionalized azole derivatives. Chem. Rec.16, 13531379. 10.1002/tcr.201500291

  • 25

    PalmieriA.PetriniM.ShaikhR. R. (2010). Synthesis of 3-substituted indoles via reactive alkylideneindolenine intermediates. Org. Biomol. Chem.8, 12591270. 10.1039/b919891a

  • 26

    PersonH.Del Aguila PardoM.FoucaudA. (1980). Reaction des isonitriles avec les β-nitrostyrenes β-substitues. Nouvelle synthese des hydroxy-1 indoles. Tetrahedron Lett.21, 281-284. 10.1016/S0040-4039(00)71189-0

  • 27

    SadjadiS.HeraviM. M.NazariN. (2016). Isocyanide-based multicomponent reactions in the synthesis of heterocycles. RSC Adv.6, 5320353272. 10.1039/c6ra02143c

  • 28

    SaegusaT.ItoY.TomitaS.KinoshitaH.Taka-IshiN. (1971). Reaction of isocyanide with α,β-unsaturated carbonyl and nitrile compounds. Tetrahedron27, 2731. 10.1016/S0040-4020(01)92394-4

  • 29

    SaegusaT.KobayashiS.ItoY.MorinoI. (1972). Reaction of isonitrile with nitroalkene. Tetrahedron28, 33893392. 10.1016/0040-4020(72)88100-6

  • 30

    ShaabaniA.TeimouriM. B.BijanzadehH. R. (2002). One-pot three component condensation reaction in water: an efficient and improved procedure for the synthesis of furo[2,3-d]pyrimidine-2,4(1H,3H)-diones. Tetrahedron Lett.43, 91519154. 10.1016/S0040-4039(02)02260-8

  • 31

    ShaikhR. R.MazzantiA.PetriniM.BartoliG.MelchiorreP. (2008). Proline-catalyzed asymmetric formal α-alkylation of aldehydes via vinylogous iminium ion intermediates generated from arylsulfonyl indoles. Angew. Chem. Int. Ed.47, 87078710. 10.1002/anie.200803947

  • 32

    ShimizuM.HachiyaI.MizotaI. (2009). Conjugated imines and iminium salts as versatile acceptors of nucleophiles. Chem. Commun.8, 874889. 10.1039/b814930e

  • 33

    ShiriM. (2012). Indoles in multicomponent processes (MCPs). Chem. Rev.112, 35083549. 10.1021/cr2003954

  • 34

    SoleimaniE.ZainaliM. (2011). Isocyanide-based multicomponent reactions: synthesis of alkyl-2-(1-(alkylcarbamoyl)-2,2-dicyanoethyl)benzoate and isochromeno[3,4-b] pyrrole derivatives. J. Org. Chem. 76, 1030610311. 10.1021/jo201908f

  • 35

    SoleimaniE.ZainaliM.GhasemiN.NotashB. (2013). Isocyanide-based multicomponent reactions: Synthesis of 2-(1-(alkylcarbamoyl)-2,2-dicyanoethyl)-N-alkylbenzamide and 1,7-diazaspiro[4,4]nonane-2,4-dione derivatives. Tetrahedron69, 98329838. 10.1016/j.tet.2013.09.011

  • 36

    SoleimaniE.ZainaliM.SamadiS. (2011). Isocyanide-based multicomponent reactions: Synthesis of 3,3-dicyano-N-alkyl-2-arylpropanamide derivatives. Tetrahedron Lett.52, 41864188. 10.1016/j.tetlet.2011.06.013

  • 37

    UgiI. (1962), The α-addition of immonium ions and anions to isonitriles accompanied by secondary reactions. Angew. Chem. Int. Ed. Engl. 1, 821. 10.1002/anie.196200081

  • 38

    WangL.ChenY.XiaoJ. (2014). Alkylideneindoleninium ions and alkylideneindolenines: Key intermediates for the asymmetric synthesis of 3-indolyl derivatives. Asian J. Org. Chem.3, 10361052. 10.1002/ajoc.201402093

  • 39

    Zarganes-TzitzikasT.ChandgudeA. L.DömlingA. (2015). Multicomponent reactions, union of MCRS and beyond. Chem. Rec.15, 981996. 10.1002/tcr.201500201

  • 40

    ZhuJ.WangQ.WangM.-X. (2015). Multicomponent Reactions in Organic Synthesis. Weinheim: Wiley-VCH.

  • 41

    ZhuoM. H.JiangY. J.FanY. S.GaoY.LiuS.ZhangS. (2014). Enantioselective synthesis of triarylmethanes by chiral imidodiphosphoric acids catalyzed friedel-crafts reactions. Org. Lett.16, 10961099. 10.1021/ol403680c

Summary

Keywords

multicomponent reactions, isocyanides, indoleninium ions, aryl(indol-3-yl)methylium ions, imidates

Citation

Golantsov NE, Nguyen HM, Golubenkova AS, Varlamov AV, Van der Eycken EV and Voskressensky LG (2019) Three-Component Reaction of 3-Arylidene-3H-Indolium Salts, Isocyanides, and Alcohols. Front. Chem. 7:345. doi: 10.3389/fchem.2019.00345

Received

27 February 2019

Accepted

26 April 2019

Published

16 May 2019

Volume

7 - 2019

Edited by

Alexander Dömling, University of Groningen, Netherlands

Reviewed by

Andrea Gualandi, University of Bologna, Italy; Diogo Seibert Lüdtke, Federal University of Rio Grande do Sul, Brazil

Updates

Copyright

*Correspondence: Erik V. Van der Eycken Leonid G. Voskressensky

This article was submitted to Organic Chemistry, a section of the journal Frontiers in Chemistry

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics